Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Covington
UBS
Baxter
Fish and Richardson
Daiichi Sankyo
Argus Health

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 9,434,785

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,434,785
Title:Anti-human OX40L antibodies and methods of treating graft versus host disease with the same
Abstract: The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Inventor(s): Bland-Ward; Philip (Cambridge, GB), Campbell; Jamie (Cambridge, GB), Holmes; Steve (Cambridge, GB), Kirby; Ian (Cambridge, GB), Kosmac; Miha (Cambridge, GB), Kean; Leslie Susan (Seattle, WA), Tkachev; Victor (Seattle, WA)
Assignee: Kymab Limited (Cambridge, GB)
Application Number:14/935,937
Patent Claims:see list of patent claims

Details for Patent 9,434,785

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Kymab Limited (Cambridge, GB) 2035-09-09 RX search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Sign Up Kymab Limited (Cambridge, GB) 2035-09-09 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ➤ Sign Up Kymab Limited (Cambridge, GB) 2035-09-09 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Sign Up Kymab Limited (Cambridge, GB) 2035-09-09 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 001 2001-05-07 ➤ Sign Up Kymab Limited (Cambridge, GB) 2035-09-09 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07 ➤ Sign Up Kymab Limited (Cambridge, GB) 2035-09-09 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Chubb
Johnson and Johnson
McKinsey
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.